Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jan;116(1):13-8.
doi: 10.1007/s10633-007-9071-z. Epub 2007 Sep 21.

Multifocal electroretinography as a predictor of maintenance of vision after photodynamic therapy for neovascular age-related macular degeneration

Affiliations

Multifocal electroretinography as a predictor of maintenance of vision after photodynamic therapy for neovascular age-related macular degeneration

Alison M Mackay et al. Doc Ophthalmol. 2008 Jan.

Abstract

Purpose: To investigate the role of multifocal electroretinography (mfERG) in predicting the outcome of photodynamic therapy (PDT) for neovascular age-related macular degeneration (AMD).

Methods: Participants underwent refraction protocol VA assessment using the ETDRS logMAR chart at 1 m, Contrast Sensitivity (CS) using the Pelli-Robson chart at 1 m, fundus fluorescein angiography (FA) and mfERGs in response to 19 segments. Response to PDT was binary (1 = the loss of less than 15 letters at 12 months, 0 = the loss of 15 letters or more) and was used as the dependent variable for logistic regression analysis.

Results: Logistic regression modelling identified mfERG central segment amplitude, lesion size on FA, VA and CS as predictors of outcome (P = 0.05, 0.02, 0.01, 0.03). The model is stable and has excellent discriminability.

Conclusion: The outcomes of this study are particularly relevant to patients in the UK who are sometimes treated with PDT alone. A larger prospective study would facilitate development of an index to predict outcome of future treatments for AMD.

PubMed Disclaimer

References

    1. Br J Ophthalmol. 2005 Mar;89(3):312-5 - PubMed
    1. Doc Ophthalmol. 2006 Jul;113(1):21-7 - PubMed
    1. Ophthalmology. 1991 May;98(5 Suppl):741-56 - PubMed
    1. J Fr Ophtalmol. 2004 Jan;27(1):79-80 - PubMed
    1. Am J Ophthalmol. 2003 Sep;136(3):407-18 - PubMed

Substances

LinkOut - more resources